Cybin Inc. Common Stock
Support and Resistance Levels
Past performance
News About HELP
All events for HELP
All deals for HELP
Financial Ratios
Financial Statements
HELP vs Sector & Peers
About Cybin Inc. Common Stock
Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder. Website helus.com
Headquarters Toronto, ON, CA